Hegele A - Search Results

1

Histological detection of minimal metastatic disease in inguinal non-sentinel lymph nodes in penile cancer.

Naumann CM, Macquarrie A, Van Der Horst C, Hamann MF, Al-Najar A, Kaufmann S, Hegele A, Korda JB, Bolenz C, Jochens A, Jünemann KP, Leuschner I. Naumann CM, et al. Among authors: hegele a. Anticancer Res. 2010 Feb;30(2):467-71. Anticancer Res. 2010. PMID: 20332456

2

Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis.

Naumann CM, Alkatout I, Al-Najar A, Korda JB, Hegele A, Bolenz C, Ziegler H, Klöppel G, Juenemann KP, van der Horst C. Naumann CM, et al. Among authors: hegele a. BJU Int. 2008 Nov;102(9):1102-6. doi: 10.1111/j.1464-410X.2008.07744.x. Epub 2008 May 16. BJU Int. 2008. PMID: 18489528

3

Lymphatic spread in squamous cell carcinoma of the penis is independent of elevated lymph vessel density.

Naumann CM, Al-Najar A, Alkatout I, Hegele A, Korda JB, Bolenz C, Kalthoff H, Sipos B, Juenemann KP, van der Horst C. Naumann CM, et al. Among authors: hegele a. BJU Int. 2009 Jun;103(12):1655-9; discussion 1659. doi: 10.1111/j.1464-410X.2009.08365.x. Epub 2009 Feb 10. BJU Int. 2009. PMID: 19220258

4

Microvessel density as a prognostic factor in penile squamous cell carcinoma.

Al-Najar A, Al-Sanabani S, Korda JB, Hegele A, Bolenz C, Herbst H, Jönemann KP, Naumann CM. Al-Najar A, et al. Among authors: hegele a. Urol Oncol. 2012 May-Jun;30(3):325-9. doi: 10.1016/j.urolonc.2010.03.016. Epub 2010 Jun 17. Urol Oncol. 2012. PMID: 21489377

5

Interobserver variation in grading and staging of squamous cell carcinoma of the penis in relation to the clinical outcome.

Naumann CM, Alkatout I, Hamann MF, Al-Najar A, Hegele A, Korda JB, Bolenz C, Klöppel G, Jünemann KP, van der Horst C. Naumann CM, et al. Among authors: hegele a. BJU Int. 2009 Jun;103(12):1660-5. doi: 10.1111/j.1464-410X.2009.08362.x. Epub 2009 Feb 9. BJU Int. 2009. PMID: 19220243

6

Squamous cell carcinoma of the penis: predicting nodal metastases by histologic grade, pattern of invasion and clinical examination.

Alkatout I, Naumann CM, Hedderich J, Hegele A, Bolenz C, Jünemann KP, Klöppel G. Alkatout I, et al. Among authors: hegele a. Urol Oncol. 2011 Nov-Dec;29(6):774-81. doi: 10.1016/j.urolonc.2009.10.014. Epub 2010 Jan 13. Urol Oncol. 2011. PMID: 20060332

7

External validation of the proposed T and N categories of squamous cell carcinoma of the penis.

Al-Najar A, Alkatout I, Al-Sanabani S, Korda JB, Hegele A, Bolenz C, Jünemann KP, Naumann CM. Al-Najar A, et al. Among authors: hegele a. Int J Urol. 2011 Apr;18(4):312-6. doi: 10.1111/j.1442-2042.2011.02722.x. Epub 2011 Feb 11. Int J Urol. 2011. PMID: 21309862

8

CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.

Hegele A, Mecklenburg V, Varga Z, Olbert P, Hofmann R, Barth P. Hegele A, et al. Anticancer Res. 2010 Dec;30(12):5195-200. Anticancer Res. 2010. PMID: 21187512

9

Non-invasive Detection of Bladder Tumors Through Volatile Organic Compounds: A Pilot Study with an Electronic Nose.

Heers H, Gut JM, Hegele A, Hofmann R, Boeselt T, Hattesohl A, Koczulla AR. Heers H, et al. Among authors: hegele a. Anticancer Res. 2018 Feb;38(2):833-837. doi: 10.21873/anticanres.12291. Anticancer Res. 2018. PMID: 29374709

10

The Immune Checkpoint Molecule CD200 Is Associated with Tumor Grading and Metastasis in Bladder Cancer.

Rexin P, Tauchert A, Hänze J, Heers H, Schmidt A, Hofmann R, Hegele A. Rexin P, et al. Among authors: hegele a. Anticancer Res. 2018 May;38(5):2749-2754. doi: 10.21873/anticanres.12517. Anticancer Res. 2018. PMID: 29715095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters